Meeting new IAPO member: Lupus and Allied Diseases Association

Members
We welcome Lupus and Allied Diseases Association, to IAPO. To help the rest of the network get to know them, they have answered a few questions about their the interesting work they do, why they are involved in patient advocacy and their thoughts and expectations as they join IAPO. Why are you...

Take our Global Survey on Access to Healthcare

Members
IAPO is conducting a series of global surveys to shadow and assess the roll out of Universal Health Coverage and factors affecting patients' access to safe , quality, acceptable and affordable healthcare globally. We are inviting you to participate in it. The level of access to healthcare that...

The political choice for patient centric and compassionate Universal Health Coverage

Press and media
First published on Health Policy Watch at Delivering Universal Health Coverage 2030 In the lead up to the UN High Level Meeting on Universal Health Coverage where the political declaration on Universal Health Coverage was adopted, Health Policy Watch published the report ‘Health: A Political...

IAPO calls upon expert patients to lead the global effort on improving patient safety today 1st World Patient Safety Day

Press and media
17 September 2019 | News Release Today the International Alliance of Patients’ Organizations calls upon expert patients to engage with and lead on the global effort to improve patient safety while marking the 1 st World Patient Safety Day. Expert patients are patients with multiple chronic...

IAPO CEO reviews the Essential Medicines List 2019

Press and media
IAPO CEO Kawaldip Sehmi was recently featured on the Global Health Matters blog as well as Health Policy Watch where he gives a review of the recently published Essential Medicines List Selection profiling the patient voice. We are pleased to be invited to contribute to these publications which...

Why the WHO’s Essential Medicines List 2019 matters to patient advocates

Press and media
On 9 th July 2019, the World Health Organization (WHO) published the updated Essential Medicines List (EML) 2019. What is it? It’s a guidance document from the WHO that helps countries prioritize critical health products that should be widely available, accessible and affordable throughout...

IAPO at the 72nd World Health Assembly

Members
Patients in full support of the development of gene and cell therapy The 72nd annual World Health Assembly ( #WHA72) took place in Geneva from 20-28 May. The IAPO team was represented throughout the WHA and hosted an event on the side-lines of the 72nd World Health Assembly. Here’s our wrap...

World Patient Safety Day adopted by 72nd World Health Assembly

Press and media
We at IAPO are extremely delighted that on Friday 24 th May 2019 the World Health Organization(WHO) Member States from all 194 countries endorsed the establishment of a World Patient Safety Day to be marked annually on 17 September and officially including it on WHO list of health dates. This is...

World Health Statistics 2019 disaggregated by sex for the first time

Members
The World Health Statistics series is the World Health Organization’s (WHO) annual compilation of health statistics for its 194 Member States. The series is produced by WHO’s Division for Data, Analytics and Delivery, in collaboration with WHO technical departments and regional offices...

Inspiring the public to take up the challenge of ending malaria

Press and media
After more than a decade of steady progress in fighting malaria, progress seems to be stalling. According to the World Health Organization’s latest World malaria report, no significant gains have been made in reducing malaria cases in the period 2015 to 2017. 2019 is therefore a critical year...

Pages